| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $430.7M | +16.2% |
| Cost of Revenue | $77.8M | +10.5% |
| Gross Profit | $352.9M | +17.5% |
| R&D Expense | $139.8M | +3.6% |
| SG&A Expense | $112.6M | +13.4% |
| Operating Income | -$96.2M | +25.6% |
| Interest Expense | $6.5M | +19.6% |
| Pre-tax Income | -$77.4M | +40.5% |
| Income Tax | -$12K |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $363.0M | +32.5% |
| Short-term Investments | $208.2M | +2.6% |
| Accounts Receivable | $100.4M | +9.9% |
| Current Assets | $703.2M | +17.1% |
| Total Assets | $925.3M | +13.1% |
| Current Liabilities | $281.7M | +3.9% |
| Long-term Debt | $489.5M | +65.1% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $72.0M | +323.9% |
| Capital Expenditures | $2.2M | -53.3% |
| Investing Cash Flow | -$30.5M | +64.6% |
| Financing Cash Flow | $51.6M | +904.6% |
| Free Cash Flow | $69.8M | +465.6% |
| +98.6% |
| Net Income | -$75.2M | +41.5% |
| EPS (Basic) | -$0.89 | +38.6% |
| EPS (Diluted) | -$0.89 | +38.6% |
| Total Liabilities |
| $746.4M |
| +29.6% |
| Stockholders' Equity | $171.6M | -28.8% |